Clinical Trial Update: Glycemic Variability of Combination Therapies in T2DM [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update for JW Pharmaceutical evaluating glycemic variability of combination therapies in Type 2 Diabetes Mellitus. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: JW Pharmaceutical | Conditions: Type 2 Diabetes Mellitus (T2DM) | Phase 4 | Status: RECRUITING